Venclexta
Showing 176 - 183 of 183
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)
Recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +3 more
-
Fountain Valley, California
- +201 more
Jan 16, 2023
Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Placebo
- +2 more
-
Tampa, Florida
- +108 more
Jul 15, 2022
Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- Venetoclax
- +2 more
-
Fullerton, California
- +219 more
Aug 24, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Fludarabine, Cyclophosphamide, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Fludarabine
- +6 more
-
Wien, Austria
- +160 more
Sep 29, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, t(11;14) Negative Trial (Dexamethasone, Ixazomib, Ixazomib
Withdrawn
- Recurrent Plasma Cell Myeloma
- +2 more
- Dexamethasone
- +3 more
- (no location specified)
Mar 25, 2019
Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))
Recruiting
- Acute Myeloid Leukemia (AML)
- Cancer
- Venetoclax
- +2 more
-
Scottsdale, Arizona
- +169 more
Aug 23, 2022
Adverse Events and Change in Disease Activity in Participants of
Recruiting
- Acute Myeloid Leukemia (AML)
-
Anjo-shi, Aichi, Japan
- +233 more
Jan 12, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
-
Birmingham, Alabama
- +484 more
Aug 24, 2022